Short potential on TGTXShort-term structural looks bullish for TGTX. But looking on bigger perspective TGTX is having structural bearishnes for years. Possible short setup at 30ish level. Shortby Patrick18120
Short TGTXA short at 17.40 to 16.57 with the necessary risk management will bring a 4.8%+ returnShortby KyleUK0
TGTX, 3/1-3/8, -2% lossOn 2/28/2024, TG Therapeutics (TGTX) reported a loss of $0.09 per share on revenue of $43.97 million for the fourth quarter ended December 2023. The consensus estimate was a loss of $0.12 per share on revenue of $40.06 million. Longby 1hour_trading0
TGTX Its a point where it can go buy from, but its a weak price point at $17 - $18. it has to show me a reversal pattern to consider buying from those prices. The best situation is if the price decreases to around $13 - $14 to buy until $25 that's 80% growth. Longby ImSoloInvestor0
TG Therapeutics Gains After Strong Q3 BeatTG Therapeutics (NASDAQ:TGTX) added ~21% pre-market Wednesday after the company posted solid topline and bottom-line beats with its Q3 2023 financials. The Morrisville, North Carolina-based biotech reported $165.8M in net revenue for the quarter, up from $94M in the prior-year period, exceeding the consensus by as much as $102.5M. A one-time payment of $140M from Neuraxpharm, its ex-U.S. partner for multiple sclerosis therapy Briumvi, boosted the top line. However, Briumvi's net sales also exceeded the company's expectations, reaching $25.1M from $16M in Q2 2023. The FDA approved the anti-CD20 monoclonal antibody in late 2022, leading to its commercial launch in January. TG Therapeutics (TGTX) recorded 900 Briumvi prescriptions for Q3, taking the total prescriptions for the drug to 2,200 since its launch. Meanwhile, the company's SG&A expenses reached $32.8M, a twofold rise from Q2 2022. However, given the strong topline growth, TG Therapeutics (TGTX) reported $113.9M in net income compared to $35.8M of net loss in the prior year period.Longby DEXWireNews2
$TGTX 4R trade ideaTGTX on pullback to the OB can benefit with a 4R is my thought. let me know what you think Longby praveen.casimir551
$TGTX LongFalling wedge within a larger broadening wedge. Daily hidden bullish divergence. Strong bull trend above the 150MA.Longby Johnno-CenturionTrading111
$TGTX - Pullback and consolidationTop trading idea for next week(s)! NASDAQ:TGTX already proved itself with a strong performance YTD of 125% (and 580% in a year). The stock is in a clear stage 2 uptrend and is now consolidating in between the 21 day MA and 50 day EMA on lower volume (check weekly chart). Has the fundamentals. A few more days of tight consolidation or a quick retest of the 50 EMA would make it even a better setup and creates a launchpad. Entry would be around 28.27 Stop breach of the 50 on high volume or a tight stop low of the day (when it breaks the pivot). Enjoy next week! Other similar ideas: NYSE:SKX , NASDAQ:WING and NASDAQ:ARCTLongby UnknownUnicorn7024067Updated 1
Pullback Buy in TGTXBiotech stocks can make huge moves, and this one is no exception. TGTX more than doubled in a month and is showing no signs of slowing down. Slower-trending, blue chip stocks tend to ride their 50-day moving average (red line on chart) on the way up. Stronger stocks tend to hold their 21-day moving average (blue line). But with high-flying honey badger stocks like TGTX, you are lucky to get a pullback to the 10-day (yellow line). TGTX touched its 10-day exponential moving average on Friday, making this the first real pullback buying opportunity since the initial surge. I would consider buying here with an 8-10% stop loss. Longby rossgivens0
TG Therapeutics. Boom! TGTXWe are moving up. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!Longby Rykin_CapitalUpdated 0
TGTX is Bull. Entering Trend Channel (after Elliot Wave)TGTX is Bull and it is entering the Trend Channel. It made an Elliot Wave, and it is rebounding to the trend. Its growth will also be fueled by XBI which is also bullish.Longby KevInnerTrading3
Elliot Wave (Failed Breakout) creates long-term growth potentialTGTX made an Elliot Wave but it failed to continue the trend after the Correction Wave and it collapsed. However, The Elliot Impulse Wave did create potential for TGTX because it built up a good Trend Channel. To continue to grow, it would need to enter Trend Channel first and then stabilize within it. The green dotted line is where it needs to go. Note: This is for Educational Purposes Only.Educationby KevInnerTradingUpdated 1
TGTX - which way shall it move?My favorite biotech... TGTX! Which way will it move?by WallStreetCharts0
Trend Reversal Confluencing Signals.Confluencing trend reversal signals as described in 'Price Action Breakdown'. I have yet to effectively apply the reading. Still trying to make sense of it. using it only when appropriate. that sort of thing.Educationby emehoke3
Buliish MACD divergence on 1D $TGTXGetting into long position with TGTX. Aslo suits for long term investment Longby Daulet_Kali0
this is what i like to seei think TGTX has an FDA approval coming up and a great cup and handle it can break out of im excited to see the price action on this on be patient with the entry good luck! if anyone knows lmk when the FDA approval is Longby nah0220
TGTX possibly breaking out of a long basing formationAfter failing to follow through on the 02/05 breakout, were now back at the 50ma with a gap fill along with decreasing volume. I think this is a hit or a miss, it'll most likely bounce strongly and make new highs or continue grinding down through the 50ma.Longby I4Updated 0
$TGTX Bull Flag$TGTX Bull Flag on the weekly's. 2 FDA drug approval catalysts going forward.Longby aviader0
TGTX, enters Downtrend as Momentum drops below 0 level on Jan 14This indicator may be signaling that TGTX's price has further to drop, since it fell below its price logged 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options. Tickeron's A.I.dvisor backtested 83 similar cases where TGTX's Momentum Indicator fell below the 0 level, and 71 of them led to a successful outcome. Odds of Success: 86%. Current price $50.00 is above $29.61 the highest resistance line found by Tickeron A.I. Throughout the month of 12/11/20 - 01/14/21, the price experienced a +21% Uptrend, while the week of 01/07/21 - 01/14/21 shows a -5% Downtrend. Bearish Trend Analysis The 10-day RSI Indicator for TGTX moved out of overbought territory on January 11, 2021. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 27 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%. The Momentum Indicator moved below the 0 level on January 14, 2021. You may want to consider selling the stock, shorting the stock, or exploring put options on TGTX as a result. In 71 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%. The Moving Average Convergence Divergence Histogram (MACD) for TGTX turned negative on December 31, 2020. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 37 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 86%. Following a 3-day decline, the stock is projected to fall further. Considering past instances where TGTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.Shortby AlTorress0
TG Therapeutics Announces Positive Topline Results from the ULTITGTX: TG Therapeutics, Inc. 2020-12-10 07:11:33 TG Therapeutics Announces Positive Topline Results from the ULTIMATE I & II Phase 3 Studies Evaluating Ublituximab Monotherapy for the Treatment of Patients with Multiple SclerosisLongby RocketTickers1
BREAKOUT CUP WITH HANDLE AND HIGH VOLUM BUY TGTX ABOUT 43.50$TG Therapeutics Soars on Positive Results for MS Treatment TG Therapeutics (TGTX) - Get Report soared Thursday after the biopharma announced positive results from two global Phase 3 studies, evaluating ublituximab, the company's treatment of multiple sclerosis patients. Shares of the New York-based company were skyrocketing nearly 42% to $42.04 in trading Thursday. 1% CAPITALLongby Benji-131
TGTX Retest of Lower Main Bull Trend Line? I have a position in TGTX with a tight stop loss for a Continuation to the Upside. It was in a Wedge Pattern that ended up breaking down to the 50MA today on the daily chart. Unfortunately, I would love to have gotten in at that position; However, I believe the bullish trend is still in tact. I did notice a nice spike in volume today, at 15:30 today, which ended up pushing the stock closing above the 30 Min 15MA. I still do not like the upper Fractal Wicks being long on the 30 Minute Time Frame, showing strong selling pressure. I will be monitoring this one daily to see a daily close above what I believe is the primary bullish trend.Longby Abatix1